SPF Fraud Cases Hard To Shake, Could Shine Light On FDA Protocol Problems
This article was originally published in The Rose Sheet
Executive Summary
As SPF defendants’ dismissal motions continue to be shot down in federal courts, it increasingly seems that their SPF claims and the radically different test results alleged by plaintiffs will have to be subjected to rigorous analysis and expert opinion, undertakings that could shine light on inherent problems with FDA’s testing protocol rather than overt moves by companies to inflate the protective capacity of their products.